{"url_path":"/sec/vbio/8-k/2026-06-03/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1787740/0001683168-26-004481-index.html","accession_number":"0001683168-26-004481","cik":"0001787740","ticker":"VBIO","issuer_name":"Valion Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1787740/0001683168-26-004481-index.html","primary_entity_key":"0001787740","primary_entity_name":"Valion Bio, Inc."},"word_count":222,"has_tables":true,"body_markdown":"**Item 5.02 Departure of Directors or Certain Officers; Election\nof Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.****\n\n* *\n\n*Amendment to the Company’s Amended and Restated\n2021 Equity Incentive Plan*\n\n* *\n\nAs described in Item 5.07 below, on May 28, 2026,\nat the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Valion Bio, Inc. (the “Company”), the Company’s\nstockholders approved an amendment (the “Plan Amendment”) to the Company’s 2021 Amended and Restated 2021 Equity Incentive\nPlan (the “2021 Plan”) to increase the number of shares of common stock authorized for issuance thereunder by 2,581,608 shares.\nThe Plan Amendment was previously approved by the Company’s Board of Directors, subject to stockholder approval, on January 29,\n2026. The Plan Amendment became effective on May 28, 2026 following receipt of stockholder approval.\n\n \n\nAdditional information regarding the Plan Amendment\nis set forth in the Company’s Definitive Proxy Statement on Schedule 14A (the “Proxy Statement”) filed by the Company\nwith the Securities and Exchange Commission on April 30, 2026, which information is incorporated herein by reference. Such information\nand the foregoing description of the Plan Amendment do not purport to be complete and are qualified in their entirety by reference to\nthe full text of the Plan Amendment, a copy of which is attached to this Current Report Exhibit 10.1 and is incorporated herein by reference."}